We are live on
!
Find out more
MA
Marshwinds Advisory Portfolio holdings
AUM
$187M
1-Year Est. Return
1.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.69%
1 Year Est. Return
-1.79%
3 Year Est. Return
+32.92%
5 Year Est. Return
+52.83%
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$5.13M
(+2.4%)
Cap. Flow
-$6.22M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
142
New
3
Increased
18
Reduced
89
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.56M |
| 2 |
AbbVie
ABBV
|
+$368K |
| 3 |
ExxonMobil
XOM
|
+$283K |
| 4 |
AGN
Allergan Inc
AGN
|
+$213K |
| 5 |
Baxter International
BAX
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$3.29M |
| 2 |
Chemours
CC
|
+$728K |
| 3 |
T
A T & T CORP (NEW)
T
|
+$520K |
| 4 |
Johnson Controls International
JCI
|
+$419K |
| 5 |
Home Depot
HD
|
+$262K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.24% |
| 2 | Consumer Staples | 16.12% |
| 3 | Technology | 16.06% |
| 4 | Healthcare | 15.65% |
| 5 | Materials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTR
126
DELISTED
Frontier Communications Corp.
FTR
| $62K | 0.03% |
1,929
-1,505
| -44% | -$68.9K |
|
127
Lee Enterprises
LEE
$172M
| $43K | 0.02% |
1,660
-291
| -15% | -$8.28K |
|
|
128
Johnson Controls International
JCI
$88.8B
| – | – |
-10,167
| Closed | -$419K |
|
129
Whirlpool
WHR
$2.43B
| – | – |
-1,225
| Closed | -$223K |
|
|
CDK
130
DELISTED
CDK Global, Inc.
CDK
| – | – |
-3,964
| Closed | -$237K |
|
|
SE
131
DELISTED
Spectra Energy Corp Wi
SE
| – | – |
-5,092
| Closed | -$209K |
|
|
STJ
132
DELISTED
St Jude Medical
STJ
| – | – |
-41,015
| Closed | -$3.29M |
|
|
DNY
133
DELISTED
DONNELLEY R R & SONS CO
DNY
| – | – |
-11,111
| Closed | -$181K |
|
Similar funds
GIM
WA
PCM
WAM
MBA
CC
KA
PPC
Marshwinds Advisory's Q1 2017 Portfolio in Review
As of Q1 2017, Marshwinds Advisory held 142 positions worth $215M, up 2.4% from $210M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Marshwinds Advisory's Q1 2017 filing shows 3 new, 18 increased, 89 reduced and 6 closed positions. Its largest new stake was Allergan Inc: 892 shares worth $213K. The largest sale was St Jude Medical, an estimated $3.29M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.
- Marshwinds Advisory's largest Q1 2017 buy was Allergan Inc: 892 shares worth $213K.
- Marshwinds Advisory added most to Abbott in Q1 2017, an estimated $1.56M increase.
- Marshwinds Advisory's biggest Q1 2017 reduction was Chemours, cutting an estimated $728K.
- Marshwinds Advisory fully exited St Jude Medical in Q1 2017, selling an estimated $3.29M.
- Marshwinds Advisory's ten largest holdings make up 25% of its $215M portfolio in Q1 2017.
- Marshwinds Advisory opened 3 new positions and closed 6 in Q1 2017.
- Marshwinds Advisory's portfolio value rose 2.4% quarter-over-quarter to $215M.
Based on Marshwinds Advisory's 13F filing for Q1 2017, filed 12 Apr 2017.